Browse the evidence

Obesity-induced hypogonadism reduces testosterone and FSH levels, disrupting the blood-testis barrier and spermatogenesis.

Obesity alters your reproductive hormones by converting testosterone to estrogen, which lowers the testosterone needed for sperm production. Weight loss can help restore these hormone levels.

Obesity increases scrotal temperature due to increased scrotal adiposity, which reduces sperm motility and concentration and increases DNA damage.

Excess fat around the scrotum traps heat, which damages sperm. Reducing this fat can lower testicular temperature and improve sperm quality.

Obesity induces chronic inflammation and oxidative stress in the reproductive tract, damaging sperm DNA and membrane lipids.

Fat tissue releases inflammatory chemicals that damage sperm DNA and membranes. Weight loss reduces this inflammation, protecting sperm integrity.

Systolic Blood Pressure (SBP) has decoupled from Body Mass Index (BMI) at the population level in high-income countries, whereas it remains positively correlated in low- and middle-income countries.

In wealthy nations, high blood pressure can be managed with medication even if BMI is high. However, in developing nations, high BMI is still a strong predictor of high blood pressure. Focus on weight management and salt reduction, especially if you live in a lower-income region.

Orexin neurons are sensitive to metabolic cues such as glucose, leptin, and ghrelin, linking energy homeostasis with vigilance states.

Regular meals and balanced nutrition support orexin function, which in turn supports wakefulness and energy levels. Avoid skipping meals, especially breakfast.

Orexin neurons are involved in emotion, stress response, and reward systems, motivating goal-directed behavior.

Stress management and emotional well-being support orexin function, which in turn supports motivation and goal-directed behavior. Practice stress-reduction techniques.

In cognitively normal elderly individuals, higher severity of obstructive sleep apnea (OSA) is associated with a faster longitudinal decrease in cerebrospinal fluid amyloid-beta 42 levels, indicating increased brain amyloid burden.

If you are over 55 and have symptoms of sleep apnea (loud snoring, gasping, daytime fatigue), getting diagnosed and treated (e.g., with CPAP) is not just about feeling rested; it may actively slow the buildup of Alzheimer's-related proteins in your brain. Prioritize sleep health as a neuroprotective strategy.

Exposure to a maternal diet rich in saturated fats during gestation and the suckling period programs offspring to develop a metabolic syndrome-like phenotype (obesity, hypertension, insulin resistance), whereas diets rich in essential fatty acids (n-3 and n-6) can normalize the offspring phenotype.

During pregnancy and breastfeeding, the type of fat you eat matters more than just the total fat amount. Diets high in saturated fats (like lard) can program your child's metabolism for obesity and insulin resistance. However, including essential fatty acids (found in fish, nuts, seeds) can help normalize development, even if total fat intake is high. Focus on fat quality.

A consistent decline in daily energy expenditure is not the primary driver of the obesity epidemic; instead, increased energy intake is the dominant factor.

Focus on managing your energy intake (diet) as the primary lever for weight loss, rather than relying solely on increasing physical activity. While exercise is beneficial for health and can aid in weight maintenance, it is not the primary driver of the obesity epidemic, which is driven by increased food energy supply.

Obesity-induced dysfunction of white adipose tissue (WAT) lipid sequestration capacity drives systemic insulin resistance by allowing toxic lipid accumulation in the liver and skeletal muscle, thereby increasing hepatic glucose output and impairing peripheral glucose disposal.

In obesity, the failure of fat cells to store fat safely leads to fat spilling into the liver and muscles, causing insulin resistance. Restoring the ability of adipose tissue to sequester lipids (e.g., through weight loss or specific metabolic therapies) is critical for resolving systemic insulin resistance, not just treating the liver or muscle directly.

Downregulation of specific adipokines (e.g., adiponectin, Neuregulin 4) and batokines (e.g., 12-HEPE, 12,13-diHOME) in obesity contributes to systemic insulin resistance by failing to suppress hepatic lipogenesis and promote peripheral glucose uptake.

Maintaining healthy adipose tissue function involves not just storage capacity but also the secretion of beneficial hormones. Obesity suppresses these protective factors (like Nrg4 and adiponectin), worsening insulin resistance. Weight loss and exercise can help restore these beneficial secretions.

Exercise-induced circadian phase shifts are not significantly different between young adults (18-30 years) and older adults (59-75 years), nor between men and women.

You do not need to adjust your exercise timing strategy based on your age or sex to achieve circadian phase shifts. The same timing principles apply to older adults as they do to younger adults.

Activation of the bile acid receptor TGR5 induces beige remodelling of white adipose tissue (scWAT) by promoting mitochondrial biogenesis and fission, thereby increasing energy expenditure and reducing adiposity.

This research identifies TGR5, a receptor activated by bile acids, as a key driver of fat-burning (beiging) in subcutaneous fat. While this is currently a pharmacological target (using mimetics like INT-777) in research, it suggests that dietary strategies influencing bile acid profiles or TGR5 activation could theoretically support metabolic health and fat loss by turning white fat into energy-expending beige fat.

A multi-tissue RNA expression signature (healthy ageing gene score) derived from muscle tissue accurately classifies biological age across muscle, brain, and skin, and higher scores in older adults are associated with better renal function, longevity, and cognitive health.

This research identifies a specific set of 150 RNA markers that can be measured from a blood sample to estimate 'biological age' and predict risks for cognitive decline and organ failure. While not yet a standard clinical test, it suggests that future blood tests could provide a more accurate assessment of health status than chronological age alone, potentially guiding preventative care for aging-related diseases like Alzheimer's.

Ghrelin is the only known orexigenic peptide hormone, stimulating food intake by activating NPY/AgRP neurons in the arcuate nucleus and inhibiting POMC neurons, with levels inversely correlated with body fat and meal status.

Ghrelin is your body's natural 'hunger hormone' released by the stomach when empty. Its levels drop after eating, signaling satiety. In obesity, baseline ghrelin levels are often lower, but sensitivity may be altered. Understanding this helps recognize that hunger is a physiological signal, not just a habit.

Anorexigenic gut hormones (GLP-1, PYY, CCK, PP, OXM) are released post-prandially in proportion to caloric intake and inhibit appetite via central (ARC) and peripheral (vagal) pathways.

After eating, your gut releases hormones like GLP-1 and PYY to tell your brain you are full. These levels rise with caloric intake. Eating protein-rich meals maximizes PYY release. Respecting these signals aids natural appetite control.

Leptin, secreted by adipose tissue, signals long-term energy stores to the brain, inhibiting NPY/AgRP neurons and activating POMC neurons to reduce food intake, with levels proportional to body fat.

Leptin is a hormone from fat cells that tells your brain about long-term energy stores. Higher body fat means higher leptin. It works by suppressing hunger neurons (NPY/AgRP) and activating satiety neurons (POMC) in the brain.

Low levels of IL-6 promote satellite cell activation and muscle regeneration, whereas chronically elevated IL-6 levels drive skeletal muscle wasting and cachexia.

Understand that muscle damage and the resulting inflammatory response (including IL-6) are not inherently bad; they are the signals required for muscle repair. However, chronic, unmanaged inflammation (often seen in disease) leads to wasting. Focus on resolving acute inflammation through recovery rather than suppressing all inflammatory markers, as some are necessary for growth.

Abnormalities in the enzymatic processing of the pro-opiomelanocortin (POMC) precursor in hypothalamic neurons critically disrupt the regulation of appetite, energy homeostasis, and body composition.

Understanding weight regulation requires looking beyond simple gene presence. If you have a genetic predisposition to obesity, it may not be just about 'having the gene' but about how your body processes hormones like POMC into active forms like alpha-MSH. This suggests that treatments targeting the processing enzymes (like PC2) or the hormone receptors themselves may be necessary for those with specific processing defects, rather than just focusing on caloric intake.

In well-controlled type 2 diabetes, muscle mitochondrial ATP synthetic flux is reduced and fails to increase in response to insulin stimulation, independent of glucose transport/phosphorylation rates.

For individuals with well-controlled Type 2 Diabetes, standard insulin therapy may not fully restore muscle mitochondrial efficiency (ATP production) compared to healthy individuals, even if blood sugar is managed. This suggests that focusing solely on glucose levels might miss underlying mitochondrial inefficiencies. Prioritizing physical activity and managing lipid availability (via diet) may help support mitochondrial function, as these factors were identified as key determinants of ATP flux in this population.

Selective beta-3 adrenergic receptor (beta3AR) agonists prevent or reverse obesity and stimulate thermogenesis in animal models by inducing brown adipocytes in white fat and increasing energy expenditure, independent of food intake.

This research highlights beta-3 adrenergic receptors as a key target for treating obesity by increasing energy expenditure (thermogenesis) rather than suppressing appetite. While effective in animals, human application is complicated by lower receptor density. Future treatments may require highly selective drugs to be effective in humans.

Obesity induces selective sympathetic nervous system (SNS) overactivity, particularly directed to muscle vasculature and kidneys, which contributes to cardiovascular risk (hypertension) but fails to increase energy expenditure or promote weight loss.

Understanding that obesity involves a specific type of nervous system stress (selective SNS activation) helps reframe the condition as a physiological state rather than just a willpower issue. While this state increases cardiovascular risk, it does not actively burn fat. Treatments targeting autonomic dysfunction (like weight loss itself) may reverse these alterations.

Selective leptin resistance in obesity preserves the sympathoexcitatory effects of leptin (increasing blood pressure) while blunting its appetite-suppressing effects.

In obesity, the body may become resistant to leptin's ability to tell you to stop eating, but it remains sensitive to leptin's ability to raise blood pressure. This explains why obese individuals often have high blood pressure even if they don't feel hungry.

Bariatric surgery induces weight loss primarily through the suppression of ghrelin, a hunger-stimulating hormone, rather than solely through malabsorption.

Bariatric surgery is effective not just because it physically restricts food intake, but because it alters gut hormones like ghrelin to reduce hunger signals. This hormonal shift helps maintain weight loss long-term, even after the initial physical restriction effects diminish.